Research
Ozempic and Mounjaro may have a surprising effect on your brain
The Brief
- Ozempic and Mounjaro, blockbuster weight-loss drugs, may also influence brain health, according to growing evidence cited by ScienceDaily.
- Studies have linked GLP-1 medications to a lower risk of dementia, but the source's account of what major trials found is truncated and cannot be stated here.
Why it matters
GLP-1 drugs are widely prescribed, so any evidence of effects on dementia risk or brain health matters for patients, clinicians and researchers weighing their broader benefits.
Who’s affected
- patients taking or considering GLP-1 medications such as Ozempic or Mounjaro
- clinicians and dementia researchers
- #glp-1
- #dementia
- #brain health
- #obesity drugs
- #neuroscience
Blockbuster weight loss drugs like Ozempic and Mounjaro may do more than help people shed pounds, with growing evidence suggesting they could also influence brain health. Although studies have linked GLP-1 medications to a lower risk of dementia, major trials found that…